Loading...

Home
ETF
SOPH

SOPH

-

$

0.000

0.000(0.000%)

At close

0.000(0.000%)Aft-market

ET

$

0.000

0.000(0.000%)

At close

0.000(0.000%)Aft-market

ET

Overview Technical News

Most Trusted AI Platform for Winning Trades

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

Home
Contact
About Us
Press
Privacy
Terms of Service
Service Terms of Use

Resources

Blog
Tutorial
Help Center
Affiliate Program

Markets

Market Analysis
Crypto
Featured Screeners
AI Earnings Calendar
Market Movers
Stock Monitor
Economic Calendar
All US Stocks
All Cryptos

Tools

Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator

Features

QuantAI Alpha Pick
SwingMax Portfolio
Swing Trading
AI Stock Picker
Whales Auto Tracker
Daytrading Center
Patterns Detection
AI Screener
Financial AI Agent
Backtesting Playground
AI Earnings Prediction
Stock Monitor
Technical Analysis

News

Overview
Top News
Daily Market Brief
Earnings Analysis
Newswire
Stock News
Crypto News
Institution News
Congress News
Monitor News

Compare

TradingView
SeekingAlpha

SOPH News

SOPHiA GENETICS Partners with Synnovis to Advance Liquid Biopsy Testing

May 13 2026PRnewswire

SOPHiA GENETICS Partners with Synnovis for Liquid Biopsy Testing in the UK

May 13 2026Newsfilter

SOPHiA Genetics Reports Q1 2025 Earnings Results

May 05 2026seekingalpha

SOPHiA GENETICS Reports Strong Q1 Results with 22% Revenue Growth

May 05 2026PRnewswire

SOPHiA GENETICS Partners with Mount Sinai to Advance Cancer Research

Apr 16 2026PRnewswire

SOPHiA GENETICS (SOPH) Q4 2025 Earnings Transcript

Mar 03 2026NASDAQ.COM

SOPHiA Genetics Q4 Earnings Report Analysis

Mar 03 2026seekingalpha

SOPHiA GENETICS Reports Strong Q4 and FY 2025 Results

Mar 03 2026PRnewswire

SOPHiA GENETICS Expands U.S. Healthcare Network with Major Partnerships

Feb 10 2026PRnewswire

SOPHiA GENETICS Projects 20%-22% Revenue Growth in 2026 and Appoints New CEO

Jan 12 2026PRnewswire

SOPHiA GENETICS Reports Strong Q4 2025 Performance, Projects 20-22% Revenue Growth for 2026

Jan 12 2026PRnewswire

SOPHiA GENETICS Reports Strong Q4 2025 Performance, Expects 20-22% Revenue Growth in 2026

Jan 12 2026PRnewswire

SOPHiA GENETICS Projects 20-22% Revenue Growth for 2026

Jan 12 2026PRnewswire

SOPHiA GENETICS Reports Strong Q4 2025 Performance, Projects 20%-22% Growth for 2026

Jan 12 2026PRnewswire

SOPHiA GENETICS Partners with MD Anderson to Accelerate Cancer Data Analysis

Jan 07 2026PRnewswire

SOPHiA GENETICS Partners with MD Anderson to Accelerate Cancer Data Analysis

Jan 07 2026Newsfilter